Search - tctmd.com

Displaying 1 - 20 of 142

Sort: Relevancy | Date

News Conference News ESC 2025

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

Michael O'Riordan

August 31, 2025

News Conference News CRT 2025

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

L.A. McKeown

March 14, 2025

Presentation TCT 2024

TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry

Presenter: Marco Ferrone

October 28, 2024

News Daily News

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Caitlin E. Cox

July 03, 2024

News Conference News EuroPCR 2024

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Caitlin E. Cox

May 14, 2024

News Daily News

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Caitlin E. Cox

March 01, 2024

News Daily News

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

Caitlin E. Cox

December 07, 2023

News Conference News TCT 2023

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

L.A. McKeown

October 31, 2023

News Conference News TCT 2023

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

Caitlin E. Cox

October 26, 2023

Presentation TCT 2023

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

Presenter: Georg Nollert

October 25, 2023

Presentation TCT 2023

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Presenter: Azfar Zaman

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

Presentation TCT 2023

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Presenter: Giovanni Esposito

October 25, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Daily News

In Certain SCAD Patients With STEMI, Primary PCI May Be Beneficial

Caitlin E. Cox

August 17, 2023

News Daily News

CABG and PCI Comparable in ACS Patients With Left Main CAD

Michael O'Riordan

June 06, 2023

News Daily News

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows

Todd Neale

December 29, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Presentation TCT 2022

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Presenter: Alexandra Lansky

September 18, 2022

Advertisement

No Benefit to Routine CT Angiography After Left Main PCI: PULSE

ATTENUATE: Protective Drape Cuts Operator Radiation Dose Across Interventions

TCT 42: Sirolimus Eluting Balloon for Coronary Intervention: An All-Comers Registry

Everyone’s Glum About RECOVER IV: Where Shock Care Heads Next Is Unclear

Go Beyond Angiography in CCS to Pinpoint the Problem, Urges AID-ANGIO

Real-life Patients Do Well With Intravascular Lithotripsy: Spanish Registry

Deferred PCI Equally Safe When Decision-making’s Based on IVUS vs FFR

PARTHENOPE Adds to Polymer-Free Stent Data, But Raises ST Questions

No Mortality Signal for iFR in Real-world Use: SWEDEHEART

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Polymer-Free Amphilimus-Eluting Stents vs. Biodegradable-Polymer Everolimus-Eluting Stents in All-Comers Undergoing PCI: 1-Year Results of the PARTHENOPE Trial

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

In Certain SCAD Patients With STEMI, Primary PCI May Be Beneficial

CABG and PCI Comparable in ACS Patients With Left Main CAD

No Benefit to More-Complete Coronary Revascularization Before TAVI, Registry Shows

November 2022 News Roundup

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

TARGET All Comers Trial 5-year Outcomes and Substudy Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content